Journal of Affective Disorders
Volume 78, Issue 3 , Pages 243-247 , March 2004

Monocytic parameters in patients with dysthymia versus major depression

Received 13 November 2000 ,Revised 25 July 2002 ,Accepted 25 July 2002.

References 

  1. Anisman H, Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv. Exp. Med. Biol. 1999;461:199–233
  2. Anisman H, Ravindran AV, Griffiths J, Merali Z. IL-1β production in dysthymia before and after pharmacotherapy. Biol. Psychiatry. 1999;46:1649–1655
  3. Brambilla F, Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr. Scand. 1998;97:309–313
  4. Cervera-Enguix S, Rodrı́guez-Rosado A. Depression and monocyte dysfunction: a follow-up study. Eur. Psychiatry. 1994;9:293–298
  5. Guy W. ECDEU Assessment Manual for Psychopharmacology. Bethesda, MD: NIMH, Psychopharmacology Research Branch; 1976;
  6. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959;6:278–296
  7. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967;6:278–298
  8. Irwin M. Depression and immunity. In:  Ader R,  Felten DL,  Cohen N editor. Psychoneuroimmunology. Vol. 2:San Diego: Academic Press; 2001;p. 383–398
  9. Landmann R, Schaub B, Link S, Wacker HR. Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy. Biol. Psychiatry. 1997;41:675–681
  10. Lanquillon S, Krieg JC, Bening-Abu-Shah U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 2000;22(4):370–379
  11. Maes M. Interleukin-1β and the etiology of depression. Acta Psychiatr. Scand. 2001;103:161–162
  12. Maes M, Smith R, Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology. 1995;2:111–116
  13. Maes M, Bosmans E, Meltzer HY, Scharpé S, Suy E. Interleukin-1β: a putative mediator of HPA axis hyperactivity in major depression?. Am. J. Psychiatry. 1993;150:1189–1193
  14. Maes M, Van der Planken M, Stevens WJ, Peeters D, De Clerck LS, Bridts CH, et al. Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. J. Psychiatr. Res. 1992;26(2):125–134
  15. McAdams C, Leonard BE. Neutrophil and monocyte phagocytosis in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1993;17(6):971–984
  16. Natelson BH, Denny T, Zhou XD, LaManca JJ, Ottenweller JE, Tiersky L, et al. Is depression associated with immune activation?. J. Affect. Disord. 1999;53:179–184
  17. Owen BM, Eccleston D, Ferrier IN, Young AH. Raised levels of plasma interleukin-1β in major and postviral depression. Acta Psychiatr. Scand. 2001;103:226–228
  18. Ravindran AV, Griffiths J, Merali Z, Anisman H. Lymphocyte subsets associated with major depression and dysthymia: modification by antidepressant treatment. Psychosom. Med. 1995;57(6):555–563
  19. Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, et al. Inflammatory markers in major depression and melancholia. J. Affect. Disord. 2001;63:93–102
  20. Schlatter J, Ortuño F, Cervera S. Differences interleukine’s patterns between dysthymia and major depression. Eur. Psychiatry. 2001;16:317–319
  21. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr. Scand. 1996;94:198–204
  22. Sluzewska A, Rybakowski JK, Bosmans E, Sobieska M, Berghmans R, Maes M, et al. Indicators of immune activation in major depression. Psychiatry Res. 1996;64:161–167
  23. Song C, Kenis G, Van Gastel A, Bosmans E, Lin A, De Jong R, et al. Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes. Psychiatry Res. 1999;85:293–303
  24. Weizman R, Laor N, Podliszewski E, Notti I, Djaldetti M, Bessler H. Cytokine production in major depressed patients before and after clomipramine treatment. Biol. Psychiatry. 1994;35:42–47
  25. Zaharia MD, Ravindran AV, Griffiths J, Merali Z, Anisman H. Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. J. Affect. Disord. 2000;58(1):1–10

PII: S0165-0327(02)00316-6

doi: 10.1016/S0165-0327(02)00316-6

Journal of Affective Disorders
Volume 78, Issue 3 , Pages 243-247 , March 2004

Article Tools